Dexcom set to launch new clinic-owned continuous glucose sensors

By staff writers

October 9, 2019 -- Dexcom has obtained U.S. Food and Drug Administration (FDA) clearance for its new G6 Pro continuous glucose monitoring (CGM) product for clinics. It plans to begin shipping G6 Pro at the start of 2020.

The single-use product provides real-time monitoring of glucose data for patients and a retrospective analysis of glucose levels over a 10-day period. G6 Pro includes a disposable sensor, with no finger-stick blood tests needed for calibration or treatment decisions, according to the company. It is intended for monitoring blood sugar and adjusting therapy for patients who have not used their own systems before, and it complements the company's G6 personal CGM product.

Dexcom announced the FDA clearance on October 8, following a June 28 decision date by the agency.

G6 Pro continuous glucose monitoring system
Dexcom has received FDA clearance for G6 Pro. Image courtesy of Dexcom.

G6 Pro can be set so that real-time information on glucose levels is given to providers only and the retrospective analysis is shared during a consultation. There is also an option, however, to share real-time information with patients through a smartphone app. A patient can be set up with the product in minutes, according to Dexcom.

Blood test spots diabetes complications early on
A prototype test that uses highly sensitive biomarkers to analyze DNA in blood is able to determine earlier and more accurately if patients with type...
Cardiologists back more screening, tight LDL and glucose control
Researchers made a strong call for genetic screening for heterozygous familial hypercholesterolemia at the European Society of Cardiology and World Congress...
Blood sugar test from GE's Drawbridge clears FDA
Drawbridge Health, a privately held company founded by GE, announced that its OneDraw single-use point-of-care device for testing hemoglobin A1c in people...
Premier Medical launches Patia's diabetes genetic test
Premier Medical Laboratory Services has announced the U.S. launch of the Diabetespredict test, which provides a genetic risk score for predisposition...

Copyright © 2019

Last Updated np 10/9/2019 1:13:06 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.